Study of the Absolute Oral Bioavailability of Dapagliflozin in Healthy Subjects

Clinical trial NCT00908271 · COMPLETED

Trial details

NCT number: NCT00908271
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2009-07-01
Primary completion: 2009-08-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.